
Ep111: Ray Stevens on Structural Biology-Driven Drug Discovery
The Long Run with Luke Timmerman
The Long Run, a Production Oftier and Report
Small molecules a, presumably available at a lower price. And in all, one of the q we are going after chronic disease. You mention their biologically validated targets b by biologic medicines. Is that part of your thinking as well? Ye and this is where different geographies, you know, come into play.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.